Varex Imaging Co. (NASDAQ:VREX – Get Rating) – Investment analysts at Oppenheimer reduced their FY2022 earnings estimates for Varex Imaging in a research report issued to clients and investors on Wednesday, August 3rd. Oppenheimer analyst S. Kalia now forecasts that the company will earn $0.64 per share for the year, down from their previous forecast of $0.68. The consensus estimate for Varex Imaging's current full-year earnings is $0.68 per share. Oppenheimer also issued estimates for Varex Imaging's Q4 2022 earnings at $0.23 EPS, Q1 2023 earnings at $0.25 EPS, Q2 2023 earnings at $0.27 EPS, Q3 2023 earnings at $0.32 EPS, Q4 2023 earnings at $0.34 EPS and FY2023 earnings at $1.19 EPS.
Get Varex Imaging alerts:Varex Imaging (NASDAQ:VREX – Get Rating) last issued its earnings results on Tuesday, August 2nd. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.16. Varex Imaging had a net margin of 3.03% and a return on equity of 10.21%. During the same quarter last year, the firm earned $0.40 EPS.
Varex Imaging Stock Down 0.1 %
Shares of NASDAQ VREX opened at $21.40 on Friday. The company has a quick ratio of 1.80, a current ratio of 3.44 and a debt-to-equity ratio of 0.78. The company's fifty day simple moving average is $21.65 and its 200 day simple moving average is $22.51. Varex Imaging has a 12-month low of $18.90 and a 12-month high of $32.65. The firm has a market cap of $851.72 million, a PE ratio of 35.08, a P/E/G ratio of 6.44 and a beta of 0.88.Insiders Place Their Bets
In other Varex Imaging news, Director Ruediger Naumann-Etienne sold 5,207 shares of the company's stock in a transaction on Monday, June 6th. The shares were sold at an average price of $22.62, for a total transaction of $117,782.34. Following the transaction, the director now owns 26,375 shares in the company, valued at $596,602.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 3.80% of the company's stock.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. Charles Schwab Investment Management Inc. raised its holdings in shares of Varex Imaging by 10.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 456,752 shares of the company's stock valued at $14,411,000 after purchasing an additional 43,009 shares during the last quarter. Comerica Bank raised its holdings in shares of Varex Imaging by 3.9% in the first quarter. Comerica Bank now owns 34,400 shares of the company's stock valued at $728,000 after purchasing an additional 1,295 shares during the last quarter. Renaissance Technologies LLC raised its holdings in shares of Varex Imaging by 291.2% in the fourth quarter. Renaissance Technologies LLC now owns 170,880 shares of the company's stock valued at $5,391,000 after purchasing an additional 127,200 shares during the last quarter. Globeflex Capital L P raised its holdings in shares of Varex Imaging by 7.1% in the fourth quarter. Globeflex Capital L P now owns 67,780 shares of the company's stock valued at $2,138,000 after purchasing an additional 4,477 shares during the last quarter. Finally, SFE Investment Counsel raised its holdings in shares of Varex Imaging by 11.3% in the fourth quarter. SFE Investment Counsel now owns 38,350 shares of the company's stock valued at $1,210,000 after purchasing an additional 3,900 shares during the last quarter.
Varex Imaging Company Profile
(Get Rating)
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys.
See Also
- Get a free copy of the StockNews.com research report on Varex Imaging (VREX)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It's Cheap
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.